CAS: 566-58-5 - 5A-pregnane-3A,20A-diol
Formula:C21H36O2
InChI:InChI=1S/C21H36O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h13-19,22-23H,4-12H2,1-3H3/t13-,14-,15+,16-,17+,18-,19-,20-,21+/m0/s1
InChI key:InChIKey=YWYQTGBBEZQBGO-CGVINKDUSA-N
SMILES:OC1CCC2(C)C(CCC3C4CCC(C(O)C)C4(C)CCC32)C1
- Synonyms:
- (3alpha,5alpha,20S)-Prgnane-3,20-diol
- (3alpha,5alpha,20S)-pregnane-3,20-diol
- (3α,5α,20S)-Pregnane-3,20-diol
- 3α,20α-Dihydroxy-5α-pregnane
- Allopregnane-3alpha,20alpha-diol
- Allopregnane-3α,20α-diol
- Allopregnanediol
- Pregnane-3,20-diol, (3α,5α,20S)-
- Prgnane-3,20-diol, (3alpha,5alpha,20S)-
Allopregnanediol (Allopregnanolone Diol Metabolite)
CAS:566-58-5
Formula:
C21H36O2
Molecular weight:
320.52
Ref: 4Z-P-3281
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 3 Dec 2024
5alpha-Pregnane-3alpha,20alpha-diol
Controlled ProductCAS:566-58-5
Applications Progesterone metabolite. References Beall, et al.: Biochem. J., 31, 35 (1937), Okuda, A., et …
Formula:
C21H36O2
Color and Shape:
Neat
Molecular weight:
320.51
Ref: TR-P705125
5mg | 244.00 € | ||
10mg | 324.00 € | ||
50mg | 1,280.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
5a-Pregnane-3a,20a-diol
Controlled ProductCAS:566-58-5
5a-Pregnane-3a,20a-diol is a gamma-aminobutyric acid (GABA) analogue that is used in the treatment of women …
Formula:
C21H36O2
Purity:
Min. 95%
Molecular weight:
320.51 g/mol
Ref: 3D-FP27149
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
5α-Pregnane-3α,20α-diol
CAS:566-58-5
5α-Pregnane-3α,20α-diol, an active metabolite of progesterone, is synthesized through intermediates 5α-pregnane-20α-ol-3-one and 5α-pregnane-3α-ol-20-one from
Formula:
C21H36O2
Color and Shape:
Liquid
Molecular weight:
320.51
Ref: TM-T83859
1mg | 147.00 € | ||
10mg | 771.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025